Spring Sleep Review: The Daytime Alternative to CPAP That Trains Your Airway While You're Awake
The Short Version
In its favour10
-
FDA-cleared for primary snoring and mild obstructive sleep apnea
a specific US regulatory clearance beyond consumer wellness marketing
-
90% of clinical trial users experienced notable snoring reduction
a clinical trial outcome percentage
-
89% of partners reported better sleep
third-party validation of the snoring reduction
-
20 minutes per day, daytime only
no overnight CPAP mask, no sleep disruption
-
Scientific Advisory Board includes Cleveland Clinic, Stanford, Mass General specialists
-
Neuromuscular electrical stimulation addresses root cause
strengthens tongue muscles to reduce airway collapse tendency
-
90-night risk-free trial with full refund
-
Telehealth prescription process
no doctor's office visit required initially
-
App-guided therapy tracking progress
-
HSA/FSA eligible
reduces effective cost
Against it6
-
$1,650 upfront
one of the most expensive consumer sleep health devices
-
$150 every 90 days ($600/year) ongoing mouthpiece subscription
-
Specifically for mild-to-moderate OSA only
not for severe cases
-
Only one main product
entire brand value rests on single device
-
Very limited independent consumer buyer review base
-
Requires consistent 20-minute daily daytime sessions
compliance challenge for busy schedules
Spring Sleep's most specific documented strength: clinical testing shows 90% of users experienced a notable reduction in nightly snoring, 78% saw reduced sleep apnea overall, and 89% of partners reported better sleep — from a device used only 20 minutes per day while awake. The eXciteOSA is FDA-cleared for primary snoring and mild obstructive sleep apnea — a specific US regulatory clearance distinguishing it from consumer wellness gadgets. Spring Sleep's Scientific Advisory Board includes ENT specialists from Cleveland Clinic, Stanford Health System, and Massachusetts General Hospital. The core proposition: for people with mild-to-moderate OSA who won't tolerate CPAP or find mandibular advancement devices uncomfortable overnight, Spring Sleep offers 20 minutes of daytime electrical stimulation — tolerable, portable, and clinically evidenced. The documented honest caveats: $1,650 upfront plus $150 every 90 days ($600/year) for replacement mouthpieces. Specifically for mild-to-moderate OSA only — not for severe cases where CPAP remains the standard of care.
What eXciteOSA Does — The Science
Obstructive sleep apnea occurs when tongue muscles relax excessively during sleep and collapse, blocking the airway. CPAP manages this during sleep by forcing air past the obstruction. eXciteOSA takes a different approach: using neuromuscular electrical stimulation during the day to strengthen tongue muscles. Stronger tongue muscles have greater baseline tone — less likely to collapse during sleep. The 6-week timeline for results reflects the time needed for measurable muscle conditioning improvement, not device limitation.
The FDA Clearance — What It Means
FDA clearance means the eXciteOSA has been reviewed and found substantially equivalent to legally marketed devices for neuromuscular electrical stimulation for oral motor therapy. It confirms regulatory review; it does not guarantee individual efficacy. The clinical studies (2018–2023) provide the efficacy evidence.
The Price Calculation
$1,650 upfront plus $600/year ongoing. Context: a CPAP machine costs $500–$1,500 upfront plus $100–$300/year supplies. A custom mandibular advancement device from a dentist costs $1,500–$3,000. HSA/FSA eligibility is the most important cost-reduction mechanism.
Our verdict
eXciteOSA Starter Pack
The single Spring Sleep product. Includes device, cleaning cap, USB-C charger, and app access. The 90-night trial allows evaluation through the 6-week minimum results timeline.
How they compare
| Product |
|---|
| Spring Sleep eXciteOSA |
| CPAP Machine |
| Custom MAD (dentist) |
| Inspire (surgery) |
| SnoreRx Plus |
| Vivos |
Spring Sleep eXciteOSA
CPAP Machine
Custom MAD (dentist)
Inspire (surgery)
SnoreRx Plus
Vivos
Also worth your money
Replacement Mouthpiece Subscription
Required for continued therapy. Budget $600/year ongoing.
What Buyers Say
Spring Sleep's products are clinically tested — 90% of tested customers experienced a notable reduction in nightly snoring. 78% found they had reduced sleep apnea overall.
eXciteOSA is a device that can easily fit into a person's daily routine — I liken it to other personal hygiene chores. Patients report it's very tolerable.
The majority of patients — greater than 90% — see some type of result within their six weeks of use during 20 minutes per day.
Spring Sleep plays an important role by offering a non-invasive daytime therapy for mild OSA. Key strengths include FDA clearance, a user-friendly app, and a telehealth-supported prescription process.
Is It Worth It?
Yes
Yes specifically for buyers with confirmed mild-to-moderate OSA who have tried or won't tolerate CPAP, can make a consistent 20-minute daily daytime session part of their routine, and have HSA/FSA access. Not for severe OSA.
Frequently asked
A FDA-cleared daytime neuromuscular electrical stimulation device for mild-to-moderate OSA. 20 minutes per day while awake. Strengthens tongue muscles to reduce airway collapse during sleep.
Clinical trials show 90% snoring reduction and 78% reduced sleep apnea. Results typically begin at 6 weeks of daily use.
Adults with mild-to-moderate OSA who want a non-overnight alternative to CPAP. Requires a prescription via Spring Sleep's telehealth process.
Not generally directly covered. HSA/FSA eligible.
Full refund within the 90-night trial per Spring Sleep's documented return policy.
The Scorecard
7.2 out of 10 overall
- FDA Clearance
- 9.5
- Clinical Evidence
- 9
- Daytime Compliance Design
- 9.5
- Medical Advisory Credibility
- 9
- Upfront Pricethe compromise
- 5
- Ongoing Subscription Cost
- 5.5
- Product Range
- 5
- Independent Buyer Reviews
- 5
The Verdict
Spring Sleep occupies a specific and clinically credible niche — a daytime alternative for mild-to-moderate OSA buyers who find CPAP compliance difficult. The FDA clearance, peer-reviewed clinical data, and institutional medical advisory board all confirm this is a legitimate medical device, not a wellness gimmick. The $1,650 upfront plus $600/year ongoing is the honest barrier — HSA/FSA access is the most practical cost management tool. The 90-night trial removes worst-case financial risk.
Every product here was chosen by an editor from the public record — verified buyer reviews, independent testing and the brand’s own documentation — before any commercial conversation happened. If you buy through a link on this page we may earn a commission, at no cost to you, and it never decides what we recommend. Read the full policy.
Editorial Team
Every recommendation on Decor Imperial is researched by our editors from the public record — verified buyer reviews, independent testing, owner communities and the brand’s own documentation — before it appears here. We earn a commission when you buy through our links; no brand sees a review before it is published, and none has ever changed one.
Keep Reading
All stories
Blog
Blog
Adanola Review: The British Clean-Girl Activewear Brand That Earned Its Viral Moment
Adanola's most specific documented strength: a ChicFitReview tester who ordered the Ultimate Leggings, cross-back bra, and pocket shorts writes "the fabric is soft yet supportive, squat-proof, and sta...
Blog
Blog
Warby Parker Review: The DTC Eyewear Brand That Changed an Industry — With Lens and Service Caveats
Warby Parker's most specific documented strength: a VisionCenter reviewer who has worn Warby Parker's Caldwell frames "daily for nearly two years" documents "I've worn glasses since I was five years o...